HSIC Filings — Henry Schein, Inc.

HSIC Filings — Henry Schein, Inc. - FilingSpy

10-Q · Quarter ended Jun 27, 2026 · SEC filing ↗

Organic sales growth decelerated to 2.5% and free cash flow turned sharply negative at -$122 million.

continued but slowed, and cash flow swung deeply negative. rose 6.7% to $3.46 billion and expanded 50 to 31.8%, but grew only 13.2% as expense growth and restructuring costs persisted, while fell to -$122 million from $6 million a year ago. The recovery is intact on the top line, but it is not yet translating into consistent earnings power or cash generation.

Key takeaways

Internally generated local-currency sales grew 2.5%, decelerating from 3.3% in Q4 FY2025, as the recovery from the October 2023 cyber incident and declining PPE sales continued to normalize.
expanded 20 to 31.8%, driven by favorable business mix and higher margins in the Distribution and Technology segments.
rose 4.0% to $182 million, held back by a 7.8% increase in operating expenses to $888 million that included $12 million in restructuring costs and a $13 million charge for shareholder advisory and consulting costs.

Section summaries

Legal Proceedings

Henry Schein states no pending legal proceedings are expected to have a material adverse effect on its financial position, liquidity, or results.

The company is involved in ordinary-course legal proceedings including product liability, employment, commercial disputes, and governmental inquiries.
Management's opinion is that none of these pending matters are currently anticipated to have a material adverse effect on the company's consolidated financial position, liquidity, or results of operations.
As of June 27, 2026, the company had accrued its best estimate of probable and reasonably estimable losses from claims, and this amount was not material.
The company's method for determining estimated losses considers currently available facts, enacted laws, and probable third-party recoveries.

HSIC

HSIC

Organic sales growth decelerated to 2.5% and free cash flow turned sharply negative at -$122 million.

Key takeaways

Section summaries

Legal Proceedings

What changed

What to watch

Risk Factors